Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins
Review articleOpen access
2014/11/12 Full-length article DOI: 10.1016/j.vaccine.2014.07.116
Highlights•Comprehensive pre-clinical immunogenicity evaluation of HPV L1 major capsid protein.•Majority neutralizing antibody response was genotype-specific.•Reciprocal cross-neutralization between some Alpha-7 and Alpha-9 genotypes.•Tetravalent formulation (HPV16/18/39/58) induced broadly neutralizing antibodies.•These data improve our understanding of the antigenic diversity of the L1 protein.
Request full text